Après plusieurs semaines de travaux, @paris l’avenue André Rivoire / David Weill est à nouveau ouverte à la circulation. Quel dommage de ne pas avoir profité des travaux pour supprimer les pavé de la piste cyclable! En plus d’être inconfortable, c’est glissant et dangereux. 🙃
#compchem New paper published in J. Phys. Chem B @JPhysChem: Incorporating Neural Networks into the AMOEBA Polarizable Force Field. Congrats to Yanxing Wang & @JaffrelotT, @leucinw. Another great collaboration with @prenbme. https://t.co/OVjauZG7bL
#compchem New #preprint: Incorporating Neural Networks into the AMOEBA Polarizable Force Field. Nice work by Yanxing Wang and @JaffrelotT.
Another great collaboration with the @prenbme group (@leucinw)
https://t.co/fOIdc4cFdG
Excited to share our latest achievement with @pasqalio about the potential of #Rydberg atom array Quantum Processing Units in our new preprint: "Leveraging Analog #QuantumComputing with Neutral Atoms for Solvent Configuration Prediction in #DrugDiscovery ! https://t.co/YELGbYjDho
📣🚀EXCITING NEWS: We've been selected for the @WellcomeLeap's "Quantum for Bio" (Q4bio) program in consortium with @pasqalio, a leader in neutral atoms quantum computing & the @unitaryfund, the leading open-source non-profit in quantum technologies!
👉: https://t.co/yJZDvhC5Ww
New #preprint in collab. with @pasqalio and @LCT_UMR7616 . These Quantum-3D-RISM algorithms open a new route towards the application of analog #quantumcomputing in molecular modelling & drug design. Great work by @loco_daniele, Nicolai Gouraud, J. Forêt, @jppiquem#compchem
#compchem Please RT.
2 PhD positions are available in my group in the context of the PhyMol EU project.
DC5 in collaboration with Alexandre Tkatchenko (UL, Luxembourg);
DC6 with Alston Misquitta (QMUL, UK).
All application details are on the website. https://t.co/tK4d9EsQKX
Thank you @perman_jorayev from @VerveVentures , for recommending Qubit Pharmaceuticals as one of the "12 startups tackling cancer to watch" - in this great article from @Siftedeu: https://t.co/8vRgYbzMdd
Attending BIO 2023? Click below to send QUBIT PHARMACEUTICALS a meeting request in the BIO partnering system! #BIO2023
Meet with our CEO Robert Marino or our COO Marion Pierrefitte and learn more about Qubit's pioneering approach to drug discovery!
https://t.co/O1cZ5VaghY
Qubit Pharmaceuticals is a laureate of the very first class of the #FrenchTech Health20. The programme ambition is to support high-potential start-ups that meet a common objective of accelerating innovation & deploy their initiatives on a large scale. https://t.co/F4nDGWgwYl